Raphael Benhamou, PhD

Raphael Benhamou, PhD of the Hebrew University of Jerusalem, is one of ICRF’s newest recipients of a Research Career Development Award (RCDA), a mentored award that supports early career scientists as they launch independent research programs. The goal of his research project is to develop targeted therapies to treat triple-negative breast cancer. He seeks to inhibit the biogenesis of small RNA molecules called micro-RNAs, or “miRNAs,” that are implicated in cancer progression. His ultimate goal is to develop therapeutic compounds against triple-negative breast cancer that can eventually be broadened to all types of cancer.

View Grant Recipient profile